Neo Ivy Capital Management Sorrento Therapeutics, Inc. Transaction History

Neo Ivy Capital Management

  • $497 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$7.41 - $10.99 $49,409 - $73,281
-6,668 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.35 - $10.0 $42,341 - $66,680
6,668 New
6,668 $65,000
Q4 2020

Feb 16, 2021
SELL
$5.76 - $11.95 $1,128 - $2,342
-196 Closed
0 $0
Q3 2020

Nov 17, 2020
BUY
$6.17 - $18.82 $1,209 - $3,688
196 New
196 $2,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.51M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email